Cancer, kidney, AIDS drugs sold at up to 70 times procurement cost: Karnataka Health Minister
Karnataka Health Minister U.T. Khader has urged the Union government to address the massive price markups on essential medicines for cancer, kidney disease, and AIDS. He proposes a national study to cap hospital-based drug prices and ensure transparency in billing.
Why it matters
Highlights systemic issues in healthcare affordability and the need for regulatory oversight on pharmaceutical pricing in hospitals.
Pointing out that high-cost medicines used to treat cancer, kidney ailments, and AIDS are being sold at prices up to “70 times higher” than the rates at which dealers and stockists procure them, Karnataka Health Minister U.T. Khader has written a letter to Union Health Minister J.P. Nadda, seeking national action against “abnormal gaps” in drug prices.
The Minister said dealers and stockists purchase advanced pharmaceuticals from manufacturers at heavily discounted wholesale landed rates, while the MRPs printed on the medicines are fixed at “inflated, highly disproportionate levels”. The letter said the gap between the procurement price and MRP was “sometimes 30 times to more than 70 times”.
Mr. Khader said that the issue was particularly concerning for in-patients, emergency and intensive-care patients, oncology patients, and those requiring implants, surgical consumables, and other hospital-based treatment, as they cannot realistically compare suppliers or defer purchases.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in